SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001618835-19-000208
Filing Date
2019-12-02
Accepted
2019-12-02 06:50:35
Documents
13
Period of Report
2019-12-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evfm8-ktoplineamprevence.htm 8-K 27325
2 EXHIBIT 99.1 exhibit991pressreleasetopl.htm EX-99.1 29983
3 EXHIBIT 99.2 exhibit992amprevence.htm EX-99.2 11744
4 amprevencetrialresultssl001.jpg GRAPHIC 62628
5 amprevencetrialresultssl002.jpg GRAPHIC 223643
6 amprevencetrialresultssl003.jpg GRAPHIC 93490
7 amprevencetrialresultssl004.jpg GRAPHIC 95504
8 amprevencetrialresultssl005.jpg GRAPHIC 97268
9 amprevencetrialresultssl006.jpg GRAPHIC 133472
10 amprevencetrialresultssl007.jpg GRAPHIC 88580
11 amprevencetrialresultssl008.jpg GRAPHIC 137004
12 amprevencetrialresultssl009.jpg GRAPHIC 91571
13 evofembiosciencesjpegfilea24.jpg GRAPHIC 61097
  Complete submission text file 0001618835-19-000208.txt   1564343
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 191262040
SIC: 2834 Pharmaceutical Preparations